Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: Schizophrenia has been associated with aberrant blood levels of inflammatory markers. However, patients with comorbid illicit drug use have been inadequately studied with respect to immune function. Furthermore, associations between inflammatory markers, psychopathology, and cognition have been inconsistently considered. We investigated relationships between inflammatory markers, comorbid marijuana and cocaine use, and psychopathology and cognition in patients with schizophrenia. Method: For subjects with available fasting data from the baseline visit of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial, inflammatory markers were investigated as predictors of psychopathology and cognition in patients with and without comorbid marijuana or cocaine use, using linear regression models controlling for potential confounding factors. Results: Compared to subjects with a negative urine drug screen (UDS), marijuana use was a predictor of higher lymphocytes and E-selectin, and lower leptin (p ≤ 0.04 for each); cocaine use was a predictor of higher adiponectin (p = 0.04). In subjects with marijuana use, lower WBC and higher IL-6 were predictors of higher PANSS total score (p < 0.05 for each). In subjects with cocaine use, lower total and differential WBC were predictors of higher PANSS total score (p < 0.04 for each). In younger, non-obese subjects with a negative UDS, higher monocytes and IL-6 were predictors of PANSS total score (p < 0.04 for each). Conclusions: Our findings provide additional evidence that inflammation may be associated with psychopathology and cognition in some patients with schizophrenia. Furthermore, there is preliminary evidence for differential effects of comorbid marijuana and cocaine use on these relationships.

Original languageEnglish (US)
Pages (from-to)275-282
Number of pages8
JournalSchizophrenia Research
Volume195
DOIs
StatePublished - May 1 2018

Fingerprint

Clinical Trials, Phase I
Cannabis
Psychopathology
Cocaine
Cognition
Antipsychotic Agents
Inflammation
Schizophrenia
Linear Models
Interleukin-6
Urine
E-Selectin
Adiponectin
Street Drugs
Leptin
Pharmaceutical Preparations
Monocytes
Fasting
Clinical Trials
Lymphocytes

Keywords

  • Cocaine
  • Cognition
  • Inflammation
  • Marijuana
  • Psychopathology
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

@article{b13188f3f9d846c8a1b8e04c8f18b3a1,
title = "Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study",
abstract = "Introduction: Schizophrenia has been associated with aberrant blood levels of inflammatory markers. However, patients with comorbid illicit drug use have been inadequately studied with respect to immune function. Furthermore, associations between inflammatory markers, psychopathology, and cognition have been inconsistently considered. We investigated relationships between inflammatory markers, comorbid marijuana and cocaine use, and psychopathology and cognition in patients with schizophrenia. Method: For subjects with available fasting data from the baseline visit of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial, inflammatory markers were investigated as predictors of psychopathology and cognition in patients with and without comorbid marijuana or cocaine use, using linear regression models controlling for potential confounding factors. Results: Compared to subjects with a negative urine drug screen (UDS), marijuana use was a predictor of higher lymphocytes and E-selectin, and lower leptin (p ≤ 0.04 for each); cocaine use was a predictor of higher adiponectin (p = 0.04). In subjects with marijuana use, lower WBC and higher IL-6 were predictors of higher PANSS total score (p < 0.05 for each). In subjects with cocaine use, lower total and differential WBC were predictors of higher PANSS total score (p < 0.04 for each). In younger, non-obese subjects with a negative UDS, higher monocytes and IL-6 were predictors of PANSS total score (p < 0.04 for each). Conclusions: Our findings provide additional evidence that inflammation may be associated with psychopathology and cognition in some patients with schizophrenia. Furthermore, there is preliminary evidence for differential effects of comorbid marijuana and cocaine use on these relationships.",
keywords = "Cocaine, Cognition, Inflammation, Marijuana, Psychopathology, Schizophrenia",
author = "Miller, {Brian J} and Buckley, {Peter F} and McEvoy, {Joseph Patrick}",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.schres.2017.08.027",
language = "English (US)",
volume = "195",
pages = "275--282",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",

}

TY - JOUR

T1 - Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study

AU - Miller, Brian J

AU - Buckley, Peter F

AU - McEvoy, Joseph Patrick

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Introduction: Schizophrenia has been associated with aberrant blood levels of inflammatory markers. However, patients with comorbid illicit drug use have been inadequately studied with respect to immune function. Furthermore, associations between inflammatory markers, psychopathology, and cognition have been inconsistently considered. We investigated relationships between inflammatory markers, comorbid marijuana and cocaine use, and psychopathology and cognition in patients with schizophrenia. Method: For subjects with available fasting data from the baseline visit of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial, inflammatory markers were investigated as predictors of psychopathology and cognition in patients with and without comorbid marijuana or cocaine use, using linear regression models controlling for potential confounding factors. Results: Compared to subjects with a negative urine drug screen (UDS), marijuana use was a predictor of higher lymphocytes and E-selectin, and lower leptin (p ≤ 0.04 for each); cocaine use was a predictor of higher adiponectin (p = 0.04). In subjects with marijuana use, lower WBC and higher IL-6 were predictors of higher PANSS total score (p < 0.05 for each). In subjects with cocaine use, lower total and differential WBC were predictors of higher PANSS total score (p < 0.04 for each). In younger, non-obese subjects with a negative UDS, higher monocytes and IL-6 were predictors of PANSS total score (p < 0.04 for each). Conclusions: Our findings provide additional evidence that inflammation may be associated with psychopathology and cognition in some patients with schizophrenia. Furthermore, there is preliminary evidence for differential effects of comorbid marijuana and cocaine use on these relationships.

AB - Introduction: Schizophrenia has been associated with aberrant blood levels of inflammatory markers. However, patients with comorbid illicit drug use have been inadequately studied with respect to immune function. Furthermore, associations between inflammatory markers, psychopathology, and cognition have been inconsistently considered. We investigated relationships between inflammatory markers, comorbid marijuana and cocaine use, and psychopathology and cognition in patients with schizophrenia. Method: For subjects with available fasting data from the baseline visit of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial, inflammatory markers were investigated as predictors of psychopathology and cognition in patients with and without comorbid marijuana or cocaine use, using linear regression models controlling for potential confounding factors. Results: Compared to subjects with a negative urine drug screen (UDS), marijuana use was a predictor of higher lymphocytes and E-selectin, and lower leptin (p ≤ 0.04 for each); cocaine use was a predictor of higher adiponectin (p = 0.04). In subjects with marijuana use, lower WBC and higher IL-6 were predictors of higher PANSS total score (p < 0.05 for each). In subjects with cocaine use, lower total and differential WBC were predictors of higher PANSS total score (p < 0.04 for each). In younger, non-obese subjects with a negative UDS, higher monocytes and IL-6 were predictors of PANSS total score (p < 0.04 for each). Conclusions: Our findings provide additional evidence that inflammation may be associated with psychopathology and cognition in some patients with schizophrenia. Furthermore, there is preliminary evidence for differential effects of comorbid marijuana and cocaine use on these relationships.

KW - Cocaine

KW - Cognition

KW - Inflammation

KW - Marijuana

KW - Psychopathology

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85028085655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028085655&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2017.08.027

DO - 10.1016/j.schres.2017.08.027

M3 - Article

VL - 195

SP - 275

EP - 282

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

ER -